Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 7,302 shares at $36.77 ($268K) on 2025-09-26, disclosed to the SEC on 2025-09-30.
Scheduled sale ($268k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.77 | 3,651 | $134K | 50.0% |
| 2 | $36.77 | 3,651 | $134K | 50.0% |
| Total | $36.77 avg | 7,302 | $268K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |
| AGIO | SELL | 2025-03-04 | $141K | — | Filing → |